Bristol-Myers Squibb Company
Heterobicyclic compounds useful as modulators of IL-12, IL-23 and/or IFN.alpha. responses

Abstract:

Compounds having the following formula (I), or a stereoisomer or pharmaceutically-acceptable salt thereof, where all substituents are as defined herein, are useful in the modulation of IL-12, IL-23 and/or IFN.alpha., by acting on Tyk-2 to cause signal transduction inhibition. ##STR00001##